PharmaJet signs deal with Scancell for needle-free melanoma vaccine
Scancell is responsible for the clinical and regulatory development, as well as commercialisation of the combined product.
Scancell is responsible for the clinical and regulatory development, as well as commercialisation of the combined product.
The $68m will be used to increase Neo’s market share in key regions beyond Europe, with an immediate focus on the US.
The medical devices industry continues to be a hotbed of patent innovation. Activity is driven by increased need for homecare,...
NHS develops AI model to predict diabetic retinopathy
Alio starts trial to expand label for remote monitoring device
Firefly and Zeto team up to distribute EEG headset devices
AstraZeneca eyes up transition to eco-friendly inhaler propellant